Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 63Unknown 21Recruiting 15Terminated 11Active not recruiting 7Not yet recruiting 4Withdrawn 3Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1

Conditions

Breast Neoplasms 9Rectal Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Glioblastoma 4Esophageal Neoplasms 4Neoplasms 3Nasopharyngeal Carcinoma 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Adenocarcinoma 2Spinal Cord Neoplasms 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Rhabdomyosarcoma 1Rectal Cancer Patients 1Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pelvic Neoplasms 1

Interventions

tislelizumab 7Paclitaxel 5Radiotherapy 4Oxaliplatin 3Immune Checkpoint Inhibitors 3Carboplatin 3nedaplatin 2Radiation 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cisplatin 2Albumin-Bound Paclitaxel 2tranilast 1toripalimab 1sintilimab 1irinotecan sucrosofate 1camrelizumab 1apatinib 1anlotinib 1Surgical Procedures, Operative 1Specimen Handling 1S 1 (combination) 1Robotic Surgical Procedures 1Radiosurgery 1Pemetrexed 1Patient Reported Outcome Measures 1Observation 1Nutrition Therapy 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Esophageal Neoplasms × Radiotherapy × Clear all
NCT07324018 2026-01-08

Spirulina Derivative for Radiation Esophagitis

West China Hospital

Phase 2 Not yet recruiting
70 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06965829 2025-05-11

The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC

Shanghai Chest Hospital

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06558175 2024-08-16

REPAIR

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Not yet recruiting
48 enrolled
GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

NCT06464614 2024-06-18

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

The First Affiliated Hospital of Henan University of Science and Technology

Phase 2 Not yet recruiting
54 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡